CGAS and hepatocellular carcinoma: (2023) demonstrated that a PD-L1 antibody-expressing oncolytic virus (rgFlu/PD-L1) targets HCC cells by activating the cGAS-STING pathway, thereby enhancing CD8+ T cell function (136).